Stada Group
Diana-Melania Vanatoru is a Global Quality Agreements Manager at STADA Group since November 2022, bringing extensive experience in quality assurance and production supervision from previous roles at B. Braun Group, where responsibilities included Quality Assurance Responsible and Production Supervisor from February 2016 to November 2022. Prior to that, Diana-Melania worked as a Pharmacist at Farmacia Catena from March 2014 to November 2015 and as a Research Pharmacist at S.C. Laboratoarele Fares BioVital S.R.L from October 2012 to March 2014. Diana-Melania holds a Bachelor's degree in Pharmacy from "Victor Babes" University of Medicine and Pharmacy in Timisoara, Romania, completed in 2012.
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.